Latest News about PCVX
Recent news which mentions PCVX
From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  March 31, 2025
  From Benzinga
 
   Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
   
  
  
  March 31, 2025
  From Benzinga
 
   Nasdaq Tumbles Over 300 Points; Chicago PMI Rises In March
   
  
  
  March 31, 2025
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  March 31, 2025
  From Benzinga
 
   One Vanguard Index Fund to Buy That May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
   
  
  
  March 15, 2025
  From Motley Fool
 
   Are Small-Cap Stocks A Buy After Russell 2000 Correction?
   
  
  
  March 06, 2025
  From Benzinga
 
   Earnings Scheduled For February 25, 2025
   
  
  
  February 25, 2025
  From Benzinga
 
   1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank
   
  
  
  December 17, 2024
  From Motley Fool
 
   1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
   
  
  
  November 20, 2024
  From Motley Fool
 
   Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
   
  
  
  November 17, 2024
  From Benzinga
 
   Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  September 03, 2024
  From Benzinga
 
   Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
   
  
  
  September 03, 2024
  From Benzinga
 
   Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
   
  
  
  September 03, 2024
  From Benzinga
 
   Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
   
  
  
  April 10, 2024
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For February 27, 2024
   
  
  
  February 27, 2024
  From Benzinga
 
   "Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
   
  
  
  January 05, 2024
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
